Patents by Inventor Ramesh DEVARAPALLI

Ramesh DEVARAPALLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid State Forms of Ensifentrine
    Publication number: 20260015354
    Abstract: The present invention relates to solid state forms of Ensifentrine and methods for preparation. use and isolation of such compounds and novel process for the preparation of Ensifentrine. The present invention further relates to an improved. cost effective and industrially viable process for preparation of Ensifentrine.
    Type: Application
    Filed: June 21, 2023
    Publication date: January 15, 2026
    Applicant: Cipla Limited
    Inventors: Arijit Das, Ramanaiah Chennuru, Ramesh Devarapalli, Anjaneyaraju Indukuri, Botcha Yerramnaidu, Shrikant Suresh Mudgal, Manohar Raghunath Surve, Maruti Laxman Ghaitadkar
  • Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor
    Patent number: 12384784
    Abstract: The present invention discloses novel crystalline polymorphic forms of Acalabrutinib, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms thereof.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: August 12, 2025
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Venkata Srinivas Pullela, Srinivas Laxminarayan Pathi, Ramanaiah Chennuru, Ramesh Devarapalli, Ashok Mithun
  • POLYMORPHIC FORMS OF IBRUTINIB
    Publication number: 20220009929
    Abstract: Disclosed herein are crystalline polymorphic forms of Ibrutinib, methods for their preparation, pharmaceutical compositions comprising the polymorphic Forms, and their use thereof.
    Type: Application
    Filed: May 2, 2019
    Publication date: January 13, 2022
    Inventors: Ramanaiah CHENNURU, Srinivas Laxminarayan PATHI, Geena MALHOTRA, Ramesh DEVARAPALLI
  • NOVEL POLYMORPHS OF ACALABRUTINIB, A BRUTON'S TYROSINE KINASE INHIBITOR
    Publication number: 20220002302
    Abstract: The present invention discloses novel crystalline polymorphic forms of Acalabrutinib, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms thereof.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 6, 2022
    Inventors: Geena MALHOTRA, Venkata Srinivas PULLELA, Srinivas Laxminarayan PATHI, Ramanaiah CHENNURU, Ramesh DEVARAPALLI, Ashok MITHUN